Building a Biotech Investing Edge with Evan Markegard

In this episode of Mission Matters Business Podcast, host Adam Torres welcomes Evan Markegaard, founder and managing partner at AUGC Partners LLC, to discuss his unique edge in biotech hedge fund investing. Evan shares his journey from earning a PhD in oncology at UCSF to launching his science-driven investment fund, rooted in deep fundamental research and value investing principles. He emphasizes his focus on small-cap biotech companies in early clinical stages, leveraging his scientific background to identify promising innovations before they gain mainstream attention. Evan highlights the structural advantages in the biotech ecosystem—where large pharmaceutical companies rely on smaller startups for R&D innovation—and explains how his approach combines scientific rigor, long-term value investing, and direct engagement with company founders. Evan also reflects on the value of high-intensity networking events like iConnections Miami and the JP Morgan Healthcare Conference, which enable deep due diligence through in-person meetings with research teams. He expresses excitement about current biotech advancements, particularly novel modalities and under-the-radar companies with transformative potential. Listeners are encouraged to connect with Evan via email or LinkedIn for more information on his investment strategy and performance. The episode underscores the power of combining domain expertise with disciplined investing to uncover hidden gems in the biotech space.